Provectus Biopharmaceuticals, Inc. (PVCT) stock
PVCTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.05+0.00 (+0.39%)
Close on Oct 19, 2026Market cap $20.55MP/E –Yield –
Provectus Biopharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Provectus Biopharmaceuticals's market cap was $20.55M on Oct 19, 2026, against $30.25M a year earlier. Over the last 5 years it ranged from $19.75M to $83.07M, with a median of $36.75M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $20.55M | -12.5% |
| 2025 | Dec 31, 2025 | $23.49M | -53.5% |
| 2024 | Dec 31, 2024 | $50.48M | +25.3% |
| 2023 | Dec 29, 2023 | $40.27M | -11.1% |
| 2022 | Dec 30, 2022 | $45.31M | +96.4% |
| 2021 | Dec 31, 2021 | $23.07M | +0.2% |
| 2020 | Dec 31, 2020 | $23.02M | -6.0% |
| 2019 | Dec 31, 2019 | $24.48M | +27.7% |
| 2018 | Dec 31, 2018 | $19.18M | -36.9% |
| 2017 | Dec 29, 2017 | $30.40M | +523.2% |
| 2016 | Dec 30, 2016 | $4.88M | -93.9% |
| 2015 | Dec 31, 2015 | $79.81M | -44.7% |
| 2014 | Dec 31, 2014 | $144.24M | -57.2% |
| 2013 | Dec 31, 2013 | $337.34M | +444.7% |
| 2012 | Dec 31, 2012 | $61.93M | -30.3% |
| 2011 | Dec 30, 2011 | $88.81M | – |
See a number that looks wrong?